Brief: Cingulate reports Q2 results
Aug 11 (Reuters) - Cingulate Inc CING.O :
* . REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
CLINICAL AND BUSINESS UPDATE
* AS OF JUNE 30, 2022, CINGULATE HAD $8.2 MILLION IN CASH
AND CASH
EQUIVALENTS
* QTRLY NET LOSS PER SHARE BASIC AND DILUTED $0.36
Source text for Eikon: ID:nGNX9PMBmT
Further company coverage: CING.O
Recent news on Cingulate
See all newsBrief: Cingulate Announces Publication Of Phase 3 Adhd Trial Results In Journal Of Child And Adolescent Psychopharmacology
NASDAQ RESUMED AT 09:39 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:34 AM
NASDAQ RESUMED AT 08:30 AM
FDA declines to approve Cingulate's ADHD treatment over manufacturing issues (updated)